Shandong Weigao Group Medical Polymer Company Limited (stock code: 01066) disclosed that on 30 January 2026 it repurchased 1,112,000 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 4.97 to HKD 5.24, for a total consideration of HKD 5,616,580. After the repurchase, the number of issued shares (excluding treasury shares) stood at 4,482,205,924, while treasury shares increased to 40,126,400.

According to the information, the repurchase was executed under a mandate granted on 27 May 2025, which authorizes the company to repurchase up to 451,560,392 shares. So far, 33,478,000 shares have been repurchased under this mandate, representing 7.4138% of the company’s then-issued shares (excluding treasury shares). A moratorium period for any new issue of shares or sale or transfer of treasury shares is in effect until 01 March 2026.